Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Cancer statistics, 1998

1998 • 2,407 citations

STUDIES ON PROSTATIC CANCER

1941 • 1,498 citations

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.

1985 • 752 citations

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

1993 • 400 citations

Prostate antigen: A new potential marker for prostatic cancer

1981 • 341 citations

Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer

1999 • 318 citations

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

1998 • 266 citations

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

1998 • 223 citations

Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic Cancer

1992 • 206 citations

Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer

1999 • 169 citations

The flare phenomenon on radionuclide bone scan in metastatic prostate cancer

1984 • 146 citations

Clinical Trials in Relapsed Prostate Cancer: Defining the Target

1996 • 129 citations

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

1995 • 101 citations

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer

1998 • 93 citations

Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines

1996 • 70 citations

Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical Course

1982 • 64 citations

High-dose intravenous estrogen therapy in advanced prostatic carcinoma

1989 • 64 citations

The dynamics of prostate specific antigen in hormone refractory prostate carcinoma

1998 • 60 citations

Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials.

1998 • 53 citations

Lack of Correlation Between Prostate-Specific Antigen and the Presence of Measurable Soft Tissue Metastases in Hormone-Refractory Prostate Cancer

1996 • 50 citations

Incidence and sites of bone lesions detected by99mTc-polyphosphate scans in patients with tumors

1975 • 45 citations

The Relationship of Prostate Specific Antigen Levels and Residual Tumor Volume in Stage a Prostate Cancer

1990 • 43 citations

BIOMOLECULAR AND CLINICAL CHARACTERISTICS OF PSA AND OTHER CANDIDATE PROSTATE TUMOR MARKERS

1993 • 42 citations

Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor

1999 • 35 citations